#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary spastic paraplegia Mantle cell lymphoma recurrent Crigler-Najjar syndrome Rhabdomyosarcoma recurrent Microscopic polyangiitis Alveolar rhabdomyosarcoma Mastocytosis Endometrial cancer recurrent Intracranial calcification Congenital growth hormone deficiency Vernal keratoconjunctivitis Chemical burn Arterial tortuosity syndrome Adenomatous polyposis coli Anal cancer More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Treatment Hypereosinophilic syndrome – Basic Information Pleomorphic leiomyosarcoma Erdheim-Chester disease – Trials in Disease Sarcoidosis – Treatment Familial haemophagocytic lymphohistiocytosis – Basic Information Skin angiosarcoma – Trials in Disease Marfan’s syndrome – Treatment Hypereosinophilic syndrome – Life with Disease Splenic marginal zone lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADMILPARANT Argipressin APAZUNERSEN Cytarabine Protein C Fentanyl Crizotinib 6QC-ICG Amivantamab Fludarabine Phosphate Ph. Eur. Bupivacaine Trabectedin Epinephrine Ab-729 Lacnotuzumab Odm-208 Ibrutinib Murcidencel Chlorambucil Mk-2060 More therapies…

    Learn about Your Condition

    Krabbe's disease Hypoparathyroidism Necrotising myositis Oedema Mitral valve prolapse Morning sickness Primary adrenal insufficiency Primary amyloidosis Cluster headache Anaemia of pregnancy Cartilage injury Migraine with aura Epithelioid sarcoma Infant sedation Status epilepticus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis enterococcal
    Investigated Drugs:
    • Dalbavancin
    • Daptomycin
    • Linezolid
    Spain

  • Study on the Effect of Clobetasol Propionate on Bone Mineral Density in Patients with Bullous Pemphigoid

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clobetasol Propionate
    France

  • Study of Pamidronate for Pain Relief in Patients with Sternocostoclavicular Hyperostosis (SCCH)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bone hypertrophy
    Investigated Drugs:
    • Pamidronate Disodium
    • Sodium Chloride
    The Netherlands

  • Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

    Recruiting

    4 1 1
    Investigated Diseases:
    • Stevens-Johnson syndrome
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Glucose Monohydrate
    • Filgrastim
    France

  • Study on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis

    Recruiting

    1 1 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    • Systemic lupus erythematosus
    • Systemic scleroderma
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    Germany

  • Study on Personalized Maintenance Therapy with Rituximab and Corticosteroids for Patients with Pemphigus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pemphigus
    Investigated Drugs:
    • Rituximab
    France
Previous Page
1 … 10 11 12 13 14 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!